Domestic macroeconomic downstream has not been effectively alleviate market shocks bottoming process continues, further enhance the demand for hedge funds.Just need characteristics and medical device product prices from the "low bid" of the pharmaceutical industry policy taking into account the relative investment value of the medical device industry, or will be further recognized by the market. 
Medical reform policies to promote market expansion of the medical device industry. The medical device industry, "second five" special planning and reform of public hospitals at the county level will constitute direct policy thrust of the steady growth of the medical device industry for a period of time in the future. Reform of public hospitals at the county level and social capital to do medical or pulling a new round of medical investment boom accelerated grass-roots demand for the release of the medical equipment market, helped make the performance of the company will continue to maintain a rapid growth in the medical device industry. 
The second half of the medical device industry investment logic. County-level public hospital reform, social capital organized medicine: this is directly related to the construction of the projects and clinics instrument, replacement of medical engineeringOn behalf of companies such as still content Medical, Wandong, and Jia shares. High-tech barriers, a leader of the market segments: import substitution will be one of the main opportunities for future Chinese medical device companies to achieve high-speed growth, the market for such companies alive, since the beginning of this branch secondary market performance can be described as strong. On behalf of companies such as Kaili Tai, the highest bio-ho. Small home and new personalized medicine terminal: Urbanization in the medium and long term, the aging of the population as well as the medical consumer upgrade three supporting factors for the development of China's medical equipment industry the miniaturization, home medical equipment, such as long-term bullish market segments. On behalf of companies such as diving medical, three Connaught biological.